ANI Pharmaceuticals, Inc. (ANIP) financial statements (2021 and earlier)

Company profile

Business Address 210 MAIN STREET WEST
BAUDETTE, MN 56623
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments862433127155169
Cash and cash equivalents862433127155169
Receivables96726559462217
Inventory, net of allowances, customer advances and progress billings6148413826138
Inventory6148413826138
Prepaid expense6453412
Other undisclosed current assets 1 1 18
Total current assets:170188153132103193203
Noncurrent Assets
Property, plant and equipment414138201175
Intangible assets, net (including goodwill)1921842052321786844
Goodwill4442222
Intangible assets, net (excluding goodwill)1891802022301766642
Regulated entity, other noncurrent assets   0   
Restricted cash and investments55555  
Deferred income tax assets5238
Other noncurrent assets1111   
Other undisclosed noncurrent assets  2822261711
Total noncurrent assets:2912692782812209360
TOTAL ASSETS:461457431412323285264
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities24211988410
Accounts payable111594323
Accrued liabilities2222111
Employee-related liabilities6442211
Taxes payable4 5 2 4
Deferred revenue00
Debt131033   
Other undisclosed current liabilities4130143282484
Total current liabilities:796216639321213
Noncurrent Liabilities
Long-term debt and lease obligation1721766770121113111
Long-term debt, excluding current maturities1721766770121113111
Liabilities, other than long-term debt1470 1  
Accounts payable and accrued liabilities    1  
Other liabilities1470    
Other undisclosed noncurrent liabilities   128   
Total noncurrent liabilities:18718268198121113111
Total liabilities:265244233237153125124
Stockholders' equity
Stockholders' equity attributable to parent196213197175170160140
Common stock0000000
Treasury stock, value(2)(1)(1)(0)   
Additional paid in capital214201187179173164160
Accumulated other comprehensive loss(11)(5)(0)    
Retained earnings (accumulated deficit)(5)1811(4)(3)(4)(20)
Total stockholders' equity:196213197175170160140
TOTAL LIABILITIES AND EQUITY:461457431412323285264

Income statement (P&L) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Revenues2082072021771297656
Cost of revenue(87)(63)(73)(79)(49)(13)(11)
Gross profit:12114312998806444
Operating expenses(81)(76)(59)(42)(37)(24)(24)
Other undisclosed operating loss(56)(51)(34)(28)(22)(7)(1)
Operating income (loss):(16)163528203320
Nonoperating income (expense)
(Other Nonoperating Income (Expense))
(0)(0)(1)0(0)00
Interest and debt expense(9)(13)(0)(11)(11)(11)(1)
Income (loss) from continuing operations before equity method investments, income taxes:(26)3341792219
Other undisclosed income (loss) from continuing operations before income taxes01(14)(1)(0)00
Income (loss) from continuing operations before income taxes:(26)3201692219
Income tax expense (benefit)33(5)(17)(5)(6)9
Net income (loss) attributable to parent:(23)615(1)41529
Other undisclosed net loss available to common stockholders, basic (0)(0) (0)(0)(0)
Net income (loss) available to common stockholders, basic:(23)615(1)41529
Other undisclosed net income available to common stockholders, diluted     00
Net income (loss) available to common stockholders, diluted:(23)615(1)41529

Comprehensive Income ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Net income (loss):(23)615(1)41529
Other comprehensive loss(7)(4)(0)    
Comprehensive income (loss), net of tax, attributable to parent:(29)215(1)41529

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: